Intestinal obstruction after colorectal cancer surgery
Conditions
Interventions
Puncture ERAS group:Based on traditional ERAS protocols, electroacupuncture was administered on the day before surgery and on postoperative days 2, 3, 4, and 5. Specifically: Bilateral ST-24 (Guanmen)
bilateral SP-12 (Fu'ai) to SP-11 (Daheng) were needled at a 45-degree angle for transverse insertion along the Spleen Meridian. Electrodes from a Huatuo SZD-V electroacupuncture device were connected
Traditional ERAS group:Adhered to the perioperative management protocol outlined in the Chinese Clinical Practice Guidelines for Enhanced Recovery After Surgery (2021 Edition), with no additional elec
Sponsors
The second affiliated hospital of Zhejiang University school of medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with colorectal cancer who have a clear histopathological diagnosis; 2. Those scheduled for elective colorectal cancer surgery; 3. Aged 18 to 80, gender not limited; 4. American Society of Anesthesiologists (ASA) Anesthesia Classification Class I or II; 5. No serious underlying diseases such as respiratory, heart or lung diseases; 6. The patient agrees to receive enhanced Recovery after surgery management and the relevant treatment plan; 7. Voluntarily participate in this clinical study and sign the informed consent form; 8. Keep complete clinical data and follow-up data before, during and after the operation;
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Those whose intestinal obstruction catheters failed to be placed or who refused electroacupuncture treatment; 3. Contraindications for intestinal obstruction catheter placement or electroacupuncture; 4. Undergoing conservative treatment for tumors or having contraindications for tumor surgery; 5. The tumor has widely metastasized and cannot be palliatively resected; 6. Those who have received electroacupuncture treatment within one month before enrollment; 7. There is a cardiac pacemaker or other electrical stimulation device; 8. Have a history of any one of the following: drug abuse, alcoholism, or mental illness; 9. Those who have participated in other clinical trials;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| First bowel movement time;First fart time;Prolonged postoperative intestinal obstruction incidence;Postoperative intestinal obstruction incidence; | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of hospital bed days;Safety indicators;Unplanned secondary surgery rate;Average length of stay;Readmission rate within 31 days after surgery; | — |
Countries
China
Contacts
Public ContactWu Juan
The second affiliated hospital of Zhejiang University school of medicine
Outcome results
None listed